Biotech is full of such companies...worth a few hundred millions today, and bought out for billions tomorrow.

As Cityslicker99 said some time back, Big Pharma companies spend vastly more capital on far less likely trials, than what buying out a derisked company like RVX would cost.  

My own guess is that the last RVX press release may be the first sign of smoke/fire.  The other one is the comments by the Eli Lilly CFO which I had posted earlier.

All we need is for RVX to get out of this "how are you funding yourself" hole they have dug themselves.  Then we can go back to drooling about RVX's blinding bright future.